These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7840555)

  • 21. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase.
    Palzkill T; Botstein D
    J Bacteriol; 1992 Aug; 174(16):5237-43. PubMed ID: 1644749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OHIO-1 beta-lactamase mutants: the Arg244Ser mutant and resistance to beta-lactams and beta-lactamase inhibitors.
    Lin S; Thomas M; Mark S; Anderson V; Bonomo RA
    Biochim Biophys Acta; 1999 Jun; 1432(1):125-36. PubMed ID: 10366735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta-lactamase TEM-1 and the G238S mutant.
    Saves I; Burlet-Schiltz O; Maveyraud L; Samama JP; Promé JC; Masson JM
    Biochemistry; 1995 Sep; 34(37):11660-7. PubMed ID: 7547898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
    Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of beta-lactamase to core amino acid substitutions.
    Petrosino JF; Baker M; Palzkill T
    Protein Eng; 1999 Sep; 12(9):761-9. PubMed ID: 10506286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
    Adamski CJ; Cardenas AM; Brown NG; Horton LB; Sankaran B; Prasad BV; Gilbert HF; Palzkill T
    Biochemistry; 2015 Jan; 54(2):447-57. PubMed ID: 25489790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases.
    Petrosino J; Rudgers G; Gilbert H; Palzkill T
    J Biol Chem; 1999 Jan; 274(4):2394-400. PubMed ID: 9891008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling.
    Huletsky A; Knox JR; Levesque RC
    J Biol Chem; 1993 Feb; 268(5):3690-7. PubMed ID: 8429044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli.
    Vakulenko SB; Taibi-Tronche P; Tóth M; Massova I; Lerner SA; Mobashery S
    J Biol Chem; 1999 Aug; 274(33):23052-60. PubMed ID: 10438473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis.
    Stojanoski V; Chow DC; Hu L; Sankaran B; Gilbert HF; Prasad BV; Palzkill T
    J Biol Chem; 2015 Apr; 290(16):10382-94. PubMed ID: 25713062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.
    Ishii Y; Ohno A; Taguchi H; Imajo S; Ishiguro M; Matsuzawa H
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2269-75. PubMed ID: 8619581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.
    Brown NG; Pennington JM; Huang W; Ayvaz T; Palzkill T
    J Mol Biol; 2010 Dec; 404(5):832-46. PubMed ID: 20955714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
    Stapleton PD; Shannon KP; French GL
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1881-7. PubMed ID: 10428907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
    Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
    Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.
    Kurokawa H; Shibata N; Doi Y; Shibayama K; Kamachi K; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2981-3. PubMed ID: 12937007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability.
    Mehta SC; Rice K; Palzkill T
    PLoS Pathog; 2015 Jun; 11(6):e1004949. PubMed ID: 26030609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance.
    Hujer AM; Hujer KM; Bonomo RA
    Biochim Biophys Acta; 2001 May; 1547(1):37-50. PubMed ID: 11343789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase.
    Arlet G; Rouveau M; Philippon A
    FEMS Microbiol Lett; 1997 Jul; 152(1):163-7. PubMed ID: 9228783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of residues 104, 164, 166, 238 and 240 in the substrate profile of PER-1 beta-lactamase hydrolysing third-generation cephalosporins.
    Bouthors AT; Dagoneau-Blanchard N; Naas T; Nordmann P; Jarlier V; Sougakoff W
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1443-9. PubMed ID: 9494118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.
    Vakulenko S; Golemi D
    Antimicrob Agents Chemother; 2002 Mar; 46(3):646-53. PubMed ID: 11850243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.